Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
Abstract Background Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2021-07-01
|
| Schriftenreihe: | Journal of Veterinary Internal Medicine |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1111/jvim.16195 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|